BME BME
Company Profile ↓Company Overview
BME (BME) is a publicly traded company listed on with a market capitalization of $583.01M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Maintains a net profit margin of 99.3%.
Carries low leverage with a debt-to-equity ratio of 0.03.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $77.54M (+222.1% YoY); net profit $76.97M.
- Trailing 12 Months Year-on-year growth — revenue +222.1%, earnings +228.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 222.10% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 228.16% |
Stock Price Performance
| 1 Year: | +27.09% |
| 6 Months: | +19.65% |
| 3 Months: | +6.44% |
| 1 Month: | +0.89% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)57.62 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 99.3%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -25.97M | 20.41M | 24.07M | 77.54M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 500.13K | 393.60K | 617.09K | 566.63K |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | - | 55 | 78 | 87 |
| Pretax Income | - | -26.47M | 20.02M | 23.45M | 76.97M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -26.47M | 20.02M | 23.45M | 76.97M |
| Diluted EPS | 4.74 | -2.10 | 1.44 | 1.63 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 606.13M | 596.10M | 550.38M | 570.14M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 3.12K | 534 | 6.05K | 548 |
| Inventory | - | - | - | - | - |
| Receivables | - | 2.37M | 1.62M | 404.42K | 428.14K |
| Total Liabilities | - | 5.93M | 7.97M | 4.24M | 1.83M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 2.92K | 60.69K | 152.06K | - |
| Total Equity | - | 600.20M | 588.14M | 546.14M | 568.30M |
| Shares Outstanding | - | 13.86M | 13.94M | 13.26M | 12.92M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -874.04K | 32.02M | 65.52M | 54.58M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | 876.17K | -32.02M | -65.52M | -54.59M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | -874.04K | 32.02M | 65.52M | 54.58M |
| Net Change in Cash | - | 2.13K | -2.56K | 5.52K | -5.51K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 101.9% | 98.1% | 97.4% | 99.3% |
| ROE % | - | -4.4% | 3.4% | 4.3% | 13.5% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BME
Bankinter (BME:BKT) Stock Price Slides Despite Solid Q3 Earnings - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPOUdvY05lcWNuV2EzX2EyVW5VRDl1WlgxejFqR09BR1d5VlFRek9BT0N6U1V6dVoxSWlRX3VRSE1VRjJKSUJJcmxJbnl4eGp6M3FSNEVhNUdLeFJ0NEhmU214WWlkS3lHeHJQWXJDZFMteDJsdjhhTHRVeGMtNVM5b18zaDhwbnc3UGJVNG…
Iberdrola (BME:IBE) Stock Faces Q3 Earnings Strength And Valuation Risk - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxONWp5V3NEaW03SHhRMTljNGpYOC1hN1VPdHJmMEQySlEwamFaWm9DdHNZNHctYldtMlBlX0RpRHZkT3dIc0dYc182LXpydTM3ekFVZmVrOE8waDZHYVVxX081V3Z0aDlBTlVZbVkxRko2dFRfSGoyNm9QVWdGVWZSODE3Y2VTeXdxd3FmRD…
Arteche (BME:ART) Stock Looks Priced Right On Cash Flow Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPSUZocDNmUEZzWUVyQ2FKWlJWdjhCQklPSkc1bFRRVzlPWF9LaFc2SDdCVFZiMExMbGJ5Z1hIQUotXzZWX3dNdVJacmc3TFNDY2Y5WFNjS012Zjk3T1c5OWtSUE9nTjBaUEZmVlJXTVBSUnJodlFzX0xyN05wVWZXeVY2Z3dKUEp5STJtbC…
Unicaja Banco (BME:UNI) Stock Looks Reasonable As Its 369% 5 Year Run Continues - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPd0lZTmpaczN4SFlXaEpha0F6NnFNODh0Smh3bEVta0Z1R1UwaE5NU3I2U2dza1hmd3JYNTEzUC1YY3IzaDJ1TUdtLU9WZ0g3LVpyazNIWGgzbzdNaUhkaGVvNU90cVl5QXllU3NLemZ6SmRQOHBvTEdheFhxWUtqbnMzUVl4VEpoekVrMj…
Elecnor (BME:ENO) Stock Looks About Right Despite Its 366% Run - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQNEo4QkVmMXNsOTZqOTd4b19xSzJiT050OEhxbGFWTmtGd2JUQ2hSYWZXTHdiNmtSVnBqd21vS2xrSzdUQU5yR212cXVGamhJZzdHc2FrNEVkODAyUG40cmR2aGZjeVBDbXAxejg3dEduWHdOYjc3Z1VVVE9NTkdlTlcxYk9MMlZSXzNCbV…
Enagás (BME:ENG) Q3 Earnings Leave Dividend Support In Focus - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPVXl3X1F5NjZoUk50LVpkUjVYMTdzbGM5WVFhWWNsTF9Ka05sUFhWSExrV3ZPanN2Qlp4Xy1aNVlvOXIwaGdfRFdNSFB2M3lsTUZvZElpdTBrRlhiT05IOW9IYURCRURFb1RZczQtcC1MMzBtVkdwaUZqNkNPTFNITndzWERERnIyQ2VlT3…
BME — Frequently Asked Questions
What is the current share price of BME?
As of 2026-10-23 16:27 PDT, BME trades at $45.11 on NASDAQ/NYSE. Its 52-week range is $35.24 to $45.74.
What is the market capitalisation of BME?
BME has a market capitalisation of $583.01M on NASDAQ/NYSE.
What is the P/E ratio of BME?
BME trades at a trailing price-to-earnings (P/E) ratio of 27.67. Its price-to-book (P/B) ratio is 1.03.
What is the return on equity (ROE) of BME?
BME has a return on equity (ROE) of 13.54%.
Is BME a good stock to buy?
This page provides a data-driven analysis of BME, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.